Skip to main content
. 2024 Sep 5;9(37):39004–39012. doi: 10.1021/acsomega.4c05592

Figure 7.

Figure 7

Dose-dependent viability of HT-1080 cells versus Suc-Ala-Ala-Pro-Val-anilide-TEMPO in the presence or absence of the metalloproteinase inhibitor ilomastat.